morinidazole
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
2
Earliest trial started Sep 30, 2016 (NCT03380793)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03380793 | Phase 4 | Sep 30, 2016 | Jiangsu Hansoh Pharmaceutical Co., Ltd. |
| NCT03391440 | Phase 4 | Sep 30, 2016 | Jiangsu Hansoh Pharmaceutical Co., Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | For profit | 2 | 2 | 1 | 2016 |
1 organizations
Page 1 / 1